SCHEMBL7478166

SCHEMBL7478166

O=c1[nH]c2cc(C(F)(F)F)ccc2n(CCO)c1=O

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDE5A O76074 2/20 0.50
PDE9A O76083 2/20 0.50
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP1A2 P05177 1/20 0.46
HSP90AA1 P07900 1/20 0.46
CYP3A4 P08684 1/20 0.46
MAPT P10636 1/20 0.46
CYP2C9 P11712 1/20 0.46
TSHR P16473 1/20 0.46
NFKB1 P19838 1/20 0.46
CYP2C19 P33261 1/20 0.46
BLM P54132 1/20 0.46
PMP22 Q01453 1/20 0.46
KCNMA1 Q12791 1/20 0.46
NPSR1 Q6W5P4 1/20 0.46
CA12 O43570 1/20 0.44
CA9 Q16790 1/20 0.44
GRIA1 P42261 2/20 0.41
GRIA2 P42262 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24335140 0.92 PDE5A (0.48) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL29580737 0.92 PDE5A (0.48) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL8345718 0.86 MEN1 (0.51) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL8117343 0.84 MEN1 (0.47) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL9544064 0.83 GRIA1 (0.55) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL8346269 0.83 MEN1 (0.46) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL7359701 0.83 GRIA1 (0.58) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL29580281 0.82 ALDH1A1 (0.48) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL24335163 0.82 ALDH1A1 (0.48) PDE5APDE9AMEN1KMT2ACYP1A2
SCHEMBL7360391 0.82 GRIA1 (0.59) PDE5APDE9AMEN1KMT2ACYP1A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0799224-B1 QUINOXALINES AND DRUGS PREPARED THEREFROM BASF AG (DE) 2002-04-17 EP disclosed
US-6277850-B1 EFFICIENCY, BIOCOMPATIBILITY, TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS ABBOTT LABORATORIES 2001-08-21 US disclosed
EP-0696288-B1 QUINOXALINDIONE DERIVATIVES, THEIR PREPARATION AND THEIR USE IN DRUGS SCHERING AG (DE) 2000-09-20 EP disclosed
US-5955461-A Quinoxalinedione derivatives, their production and use in pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1999-09-21 US disclosed
US-5849743-A Quinoxalines and drugs prepared therefrom BASF AKTIENGESELLSCHAFT (DE) 1998-12-15 US disclosed
US-5750525-A Quinoxalinedione derivatives, their production and use in pharmaceutical agents SCHERING AKTIENGESELLSCHAFT (DE) 1998-05-12 US disclosed